Skip to main content
Log in

HPV vaccine after HSIL treatment cost effective in MSM

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Deshmukh AA, et al. Adjuvant HPV vaccination for anal cancer prevention in HIV-positive men who have sex with men: The time is now. Vaccine : 11 Aug 2017. Available from: URL: http://doi.org/10.1016/j.vaccine.2017.08.006

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

HPV vaccine after HSIL treatment cost effective in MSM. PharmacoEcon Outcomes News 785, 15 (2017). https://doi.org/10.1007/s40274-017-4265-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4265-4

Navigation